ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2020

The Product of Red Blood Cells and Hematocrit Can Be Used as a Novel Indicator of Impaired Fasting Blood Glucose Status.

Ling Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.